Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells

scientific article published on July 2006

Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID16773209

P2093author name stringWen Di
Yun Sun
Bingfang Yan
Yinsheng Wan
Changlin Zhou
Harold Wanebo
Lihua Qiu
Nicola Kouttab
Sarah Healey
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectovarian cancerQ172341
cell deathQ2383867
P304page(s)269-278
P577publication date2006-07-01
P1433published inInternational Journal of OncologyQ6051527
P1476titleInhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells
P478volume29

Reverse relations

cites work (P2860)
Q37200466A rationally designed histone deacetylase inhibitor with distinct antitumor activity against ovarian cancer
Q34626608Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors
Q36135360Activation of acetyl-coenzyme A carboxylase is involved in Taxol-induced ovarian cancer cell death
Q36562200Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma
Q33939652Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway
Q39761676Casein kinase 2 inhibition differentially modulates apoptotic effect of trichostatin A against epithelial ovarian carcinoma cell lines
Q28386290Constitutive activation of epidermal growth factor receptor promotes tumorigenesis of Cr(VI)-transformed cells through decreased reactive oxygen species and apoptosis resistance development
Q39580397Different effect of protein kinase B/Akt and extracellular signal-regulated kinase inhibition on trichostatin A-induced apoptosis in epithelial ovarian carcinoma cell lines
Q26863231EGFR/HER-targeted therapeutics in ovarian cancer
Q39987553Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines
Q37426890Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.
Q38959475Elucidation of caveolin 1 both as a tumor suppressor and metastasis promoter in light of epigenetic modulators.
Q44343064Epigenetic Activation of μ-Opioid Receptor Gene via Increased Expression and Function of Mitogen- and Stress-Activated Protein Kinase 1.
Q33882180GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast
Q48150376Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition.
Q33590704MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer
Q34589710PSG gene expression is up-regulated by lysine acetylation involving histone and nonhistone proteins.
Q38909468Potential for modulation of the fas apoptotic pathway by epidermal growth factor in sarcomas
Q36007656Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells
Q37612026Suppression of Excessive Histone Deacetylases Activity in Diabetic Hearts Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondria Apoptosis Pathway.
Q37485865Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.
Q36855819Unlocking repression of the human luteinizing hormone receptor gene by trichostatin A-induced cell-specific phosphatase release

Search more.